Cargando…
Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
Body mass index (BMI) is well known to be associated with poor prognosis in several cancers. The relationship between BMI and the long-term outcomes of patients with intrahepatic cholangiocarcinoma (ICC) is incompletely understood. This study investigated the relationships of BMI with clinicopatholo...
Autores principales: | Yugawa, Kyohei, Itoh, Shinji, Iseda, Norifumi, Kurihara, Takeshi, Kitamura, Yoshiyuki, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Baba, Shingo, Ishigami, Kousei, Oda, Yoshinao, Yoshizumi, Tomoharu, Mori, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955092/ https://www.ncbi.nlm.nih.gov/pubmed/33712681 http://dx.doi.org/10.1038/s41598-021-85186-6 |
Ejemplares similares
-
Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021) -
Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022) -
Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021) -
CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020) -
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)